HMCapital co-leads $56m Series B in US pharma firm OncoImmune

HMCapital co-leads $56m Series B in US pharma firm OncoImmune

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter